menu
    • menu

    Company profile for Endogena Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Endogena’s mission is to discover and develop first-in-class endogenous regenerative medicines to repair and regenerate tissues and organs. our approach has the potential for a medical treatment paradigm change to effectively address unmet medical needs associated with ageing and genetic diseases. endogena therapeutics is implementing state-of-the art innovation in the field of regenerative medicine. our science combines ...
    Endogena’s mission is to discover and develop first-in-class endogenous regenerative medicines to repair and regenerate tissues and organs. our approach has the potential for a medical treatment paradigm change to effectively address unmet medical needs associated with ageing and genetic diseases. endogena therapeutics is implementing state-of-the art innovation in the field of regenerative medicine. our science combines the latest developments in stem cell biology, artificial intelligence and our expertise in small-molecule drug design to develop breakthrough treatments for degenerative diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Endogena TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    111 Pine Street San Francisco | Ca 94111
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://endogena.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/endogena/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Endogena Therapeutics Secures FDA Green Light for Breakthrough AMD Treatment
    Endogena Therapeutics Secures FDA Green Light for Breakthrough AMD Treatment

    24 Oct 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/10/24/2765328/0/en/Endogena-Therapeutics-Secures-FDA-Green-Light-for-Breakthrough-AMD-Treatment.html

    GLOBENEWSWIRE
    24 Oct 2023
    Share Share
    Endogena completes enrolment ahead of schedule in RP therapy trial
    Endogena completes enrolment ahead of schedule in RP therapy trial

    05 May 2023

    // CLINICAL TRIALS ARENA

    https://www.clinicaltrialsarena.com/news/endogena-enrolment-ahead-of-schedule/

    CLINICAL TRIALS ARENA
    05 May 2023
    Share Share
    Endogena finalises enrolment for retinitis pigmentosa trial
    Endogena finalises enrolment for retinitis pigmentosa trial

    04 May 2023

    // John Pinching PHARMATIMES

    https://www.pharmatimes.com/news/endogena_finalises_enrolment_for_retinitis_pigmentosa_trial_1491321

    John Pinching PHARMATIMES
    04 May 2023
    Share Share
    Endogena Completes Dose Escalation in Phase 1/2a Trial of EA-2353
    Endogena Completes Dose Escalation in Phase 1/2a Trial of EA-2353

    05 Apr 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/04/05/2641564/0/en/Endogena-Therapeutics-Completes-Dose-Escalation-in-the-Phase-1-2a-Clinical-Trial-of-EA-2353-for-the-Treatment-of-Retinitis-Pigmentosa.html

    GLOBENEWSWIRE
    05 Apr 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search